SCHEMBL3350252

SCHEMBL3350252

CC(C)(C)OC(=O)NCC1Oc2c(cc(F)cc2-c2c(Cl)cccc2Cl)S1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AQP1 P29972 1/20 0.44
DRD2 P14416 2/20 0.37
LMNA P02545 3/20 0.36
HPGD P15428 2/20 0.36
GAA P10253 1/20 0.36
MEN1 O00255 2/20 0.34
KMT2A Q03164 2/20 0.34
KDM4E B2RXH2 2/20 0.34
ACACB O00763 1/20 0.34
ACACA Q13085 1/20 0.34
ALDH1A1 P00352 1/20 0.34
HTT P42858 1/20 0.34
NCOA1 Q15788 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
NCOA3 Q9Y6Q9 1/20 0.34
RORC P51449 3/20 0.34
TSHR P16473 2/20 0.34
EPAS1 Q99814 1/20 0.34
ABL1 P00519 1/20 0.34
PDGFRB P09619 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3343391 0.85 AQP1 (0.49) AQP1DRD2LMNAHPGDGAA
SCHEMBL13306794 0.79 AQP1 (0.43) AQP1DRD2LMNAHPGDGAA
SCHEMBL3343344 0.77 AQP1 (0.45) AQP1
SCHEMBL13306787 0.76 AQP1 (0.48) AQP1DRD2LMNAHPGDGAA
SCHEMBL3343837 0.75 AQP1 (0.45) AQP1
SCHEMBL3343327 0.70 AQP1 (0.40) AQP1ALDH1A1TSHRMAPK1CYP3A4
SCHEMBL14194636 0.70 AQP1 (0.40) AQP1
SCHEMBL8228892 0.68 DRD2 (0.43) AQP1DRD2LMNAHPGDGAA
SCHEMBL3347355 0.67 AQP1 (0.54) AQP1
SCHEMBL4959730 0.66 AQP1 (0.74) AQP1LMNAGAAKMT2ARORC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100160411-A1 BENZOXATHIINE AND BENZOXATHIOLE DERIVATIVES AND USES THEREOF WYETH (US) 2010-06-24 US disclosed
US-20100160411-A1 BENZOXATHIINE AND BENZOXATHIOLE DERIVATIVES AND USES THEREOF WYETH (US) 2010-06-24 US disclosed
US-20100160411-A1 BENZOXATHIINE AND BENZOXATHIOLE DERIVATIVES AND USES THEREOF WYETH (US) 2010-06-24 US disclosed
WO-2008052078-A2 BENZOXATHIINE AND BENZOXATHIOLE DERIVATIVES AND USES THEREOF WYETH (US) 2008-05-02 WO disclosed
WO-2008052078-A2 BENZOXATHIINE AND BENZOXATHIOLE DERIVATIVES AND USES THEREOF WYETH (US) 2008-05-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100160411-A1 BENZOXATHIINE AND BENZOXATHIOLE DERIVATIVES AND USES THEREOF HTR2C, HTR3B, HTR1A AQP1 2605/4885DRD2 69/4885LMNA 2524/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.